Tag: MEDITE Cancer Diagnostics
MEDITE Cancer Diagnostics, Inc. Reports 2015 Q2 and Six Month Results, Increases Equity
ORLANDO, Fla. /Florida Newswire/ -- MEDITE Cancer Diagnostics, Inc. ('Company,' OTCQB symbol: MDIT / OTCBB:MDIT / OTCMKTS:MDIT), specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces second quarter and six month 2015 results.
MEDITE Cancer Diagnostics, Inc. Announces Change of Auditor, engaging WithumSmith+Brown, P.C.
ORLANDO, Fla. /Florida Newswire/ -- Cancer Diagnostics, Inc. (OTCQB symbol: 'MDIT' / OTCBB:MDIT), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces change of auditors.
